Multiple myeloma, version 2.2016: Clinical practice guidelines in oncology

Kenneth C. Anderson, Melissa Alsina, Djordje Atanackovic, J. Sybil Biermann, Jason C. Chandler, Caitlin Costello, Benjamin Djulbegovic, Henry C. Fung, Cristina Gasparetto, Kelly Godby, Craig Hofmeister, Leona Holmberg, Sarah Holstein, Carol Ann Huff, Adetola Kassim, Amrita Y. Krishnan, Shaji K. Kumar, Michaela Liedtke, Matthew Lunning, Noopur RajeSeema Singhal, Clayton Smith, George Somlo, Keith Stockerl-Goldstein, Steven P. Treon, Donna Weber, Joachim Yahalom, Dorothy A. Shead, Rashmi Kumar

Research output: Contribution to journalReview articlepeer-review

60 Scopus citations


Multiple myeloma (MM) is a malignant neoplasm of plasma cells that accumulate in bone marrow, leading to bone destruction and marrow failure. Recent statistics from the American Cancer Society indicate that the incidence of MM is increasing. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) included in this issue address management of patients with solitary plasmacytoma and newly diagnosed MM.

Original languageEnglish
Pages (from-to)1398-1435
Number of pages38
JournalJournal of the National Comprehensive Cancer Network : JNCCN
Issue number11
StatePublished - Nov 1 2015


  • Disease Management
  • Humans
  • Multiple Myeloma/diagnosis


Dive into the research topics of 'Multiple myeloma, version 2.2016: Clinical practice guidelines in oncology'. Together they form a unique fingerprint.

Cite this